United States · Investor

Eventide

Filed with the SEC to raise a fund in Nov 2023, closing $65M. Last cheque observed Mar 2019.

QuietNew fund $65M, Nov 2023VC firm

SeedSeries ASeries BHealthcare

Cheques on record
0%of best year0cheques in 12 months, 4 on record
Since the last cheque2779days00hrs00min00sec
Median round$64MRounds led0 of 4
Pitch Eventide

Eventide highlights

  1. 01

    4 rounds on record

  2. 02

    Mostly Series B and Series C: 67% of its rounds

What they do

We launched our first values-based mutual fund in 2008 and now offer eight different funds across an array of investment strategies.From their own website
Type
VC firm (from a list, unverified)
Cheque size
Not stated
Stages
SeedSeries ASeries BGrowth
Sectors
Healthcare
Based in
Boston, United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first4 appearances

  1. 2019

    1 round

  2. Mar
    Karuna TherapeuticsSeries B · US · FinSMEs$68MWith 8 others
  3. 2018

    3 rounds

  4. Jun
    SutroSeries E · US · FinSMEs$85MWith 17 others
  5. Apr
    Magenta TherapeuticsSeries C · US · FinSMEs$52MWith 4 others
  6. Feb
    AvrobioUS · FinSMEs$60MWith 7 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration6 named

DBDolores BamfordCo-CIO of the ManageriFiling they signed
FKFinny KuruvillaCo-CIO of the Manager, Managing DirectoriFiling they signed
JRJennifer ReicheChief Compliance Officer of the ManageriFiling they signed
KRKyle RasbachManaging Director of the ManageriFiling they signed
RJRobin JohnChief Executive Officer of the ManageriFiling they signed
SMSean MathewChief Financial Officer of the ManageriFiling they signed

We also hold 5 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Who they invest alongside

The investors most often in the same rounds as Eventide. A count of rooms they were both in, not a relationship either has claimed.

Pivotal bioVenture PartnersVC firm2rounds together

Recently backed

The latest companies Eventide put money into.

Magenta Therapeutics$52M · Apr 2018Avrobio$60M · Feb 2018

Quick answers about Eventide

What does Eventide invest in?

Eventide invests most often at Series B and Series C (67% of the rounds on record), in sectors such as Healthcare.

How active is Eventide?

4 investments on record, 0 of them in the last 12 months. The most recent was in Mar 2019.

What has Eventide invested in recently?

Its most recent investments on record: Karuna Therapeutics (Series B, Mar 2019), Sutro (Series E, Jun 2018) and Magenta Therapeutics (Series C, Apr 2018).

How big are Eventide's cheques?

The median round it joins is $64M.

Is Eventide investing now?

No investments in the last 12 months; the latest was in Mar 2019.

Who does Eventide invest alongside?

Most often Pivotal bioVenture Partners (2 rounds together).

What kind of investor is Eventide?

Eventide is a VC firm based in Boston, United States.

Has Eventide raised a new fund?

Its latest fund filing with the SEC was in Nov 2023, reporting $65M raised.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it